Articles

How can early identification of patient-specific risk factors help optimize patient outcomes and proactively manage toxicity with ADC therapy? In this video, Tajuana Bradley, DNP, FNP-BC, AOCNP, and Abbey Kaler, PA-C, discuss approaches to evaluating baseline risk factors, identifying patients who may be at increased risk for key ADC-related toxicities, and implementing monitoring, multidisciplinary care, and patient education strategies at treatment initiation. Read More ›

Stream the Case-Based Exchange Webinar: “High-Risk, Node-Positive, HR-Positive/HER2-Negative Early Breast Cancer” to hear perspectives on markers of high-risk disease and practical treatment approaches from Neil Iyengar, MD, and Annalise Labatut, PharmD, BCOP, of the Winship Cancer Institute of Emory University. Topics include the role of the CDK4/6 inhibitor in adjuvant treatment. Read More ›

In this episode, we sit down with Kem Tolliver, President and CEO of Medical Revenue Cycle Specialists and a nationally recognized expert in practice management and revenue cycle optimization, to unpack why oncology’s financial infrastructure is uniquely complex and why getting it right directly impacts patient access and outcomes. From denial prevention to workflow redesign, Kem shares actionable insights every oncology leader should hear. Read More ›

Most cancer care happens in community settings—and oncology nurses are at the center of it. Ryne Wilson, DNP, RN, OCN, CNE, President of the Oncology Nursing Society, joins us to discuss how nurses are managing complex symptoms, navigating patient barriers, and using new clinical tools to deliver smarter, more coordinated care—plus what’s next for the profession. Read More ›

In this episode, we sit down with Jennifer R. Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, to unpack the AMPLIFY trial that is reshaping chronic lymphocytic leukemia (CLL) treatment. She explains how this new oral combination isn’t just effective but patient-friendly, cutting down on complexity and paving the way for more accessible care. Tune in to hear how this breakthrough is setting the stage for the future of CLL therapy. Read More ›